- Report
- May 2025
- 80 Pages
From €2658EUR$2,950USD£2,279GBP
- Report
- May 2025
- 95 Pages
Asia Pacific
From €3109EUR$3,450USD£2,666GBP
- Report
- May 2025
- 98 Pages
Europe
From €3109EUR$3,450USD£2,666GBP
- Report
- May 2025
- 88 Pages
North America
From €2658EUR$2,950USD£2,279GBP
- Report
- April 2025
- 210 Pages
Global
From €4055EUR$4,500USD£3,477GBP
- Report
- April 2025
- 180 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- March 2025
- 131 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- February 2025
- 130 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- January 2025
- 166 Pages
Global
From €4190EUR$4,650USD£3,593GBP
- Report
- October 2024
- 141 Pages
Poland
From €1379EUR$1,530USD£1,182GBP
€1622EUR$1,800USD£1,391GBP
- Report
- October 2024
- 70 Pages
Latin America
From €856EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
China
From €856EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
France
From €856EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Germany
From €856EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
India
From €856EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €856EUR$950USD£734GBP
- Report
- October 2024
- 93 Pages
Global
From €4055EUR$4,500USD£3,477GBP
- Report
- June 2024
- 310 Pages
Global
From €2208EUR$2,450USD£1,893GBP
- Report
- June 2024
- 185 Pages
Global
From €5001EUR$5,550USD£4,288GBP
- Report
- June 2023
- 35 Pages
Italy
From €3600EUR$3,995USD£3,087GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more